[PHARMA] QoQ Cumulative Quarter Result on 31-Dec-2009 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
19-Feb-2010
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2009
Quarter
31-Dec-2009 [#4]
Profit Trend
QoQ- 57.24%
YoY- 0.27%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
Revenue 1,002,232 667,895 317,560 1,300,796 976,890 646,928 313,716 116.76%
PBT 48,163 32,758 12,431 81,436 53,948 44,521 20,184 78.47%
Tax -15,901 -8,931 -3,122 -19,709 -14,337 -11,305 -5,491 103.03%
NP 32,262 23,827 9,309 61,727 39,611 33,216 14,693 68.85%
-
NP to SH 32,640 24,054 9,307 60,191 38,279 32,219 14,522 71.50%
-
Tax Rate 33.01% 27.26% 25.11% 24.20% 26.58% 25.39% 27.20% -
Total Cost 969,970 644,068 308,251 1,239,069 937,279 613,712 299,023 118.97%
-
Net Worth 424,715 417,306 439,675 431,158 407,610 400,063 402,378 3.66%
Dividend
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
Div 50,281 50,290 - 39,585 28,885 28,881 - -
Div Payout % 154.05% 209.07% - 65.77% 75.46% 89.64% - -
Equity
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
Net Worth 424,715 417,306 439,675 431,158 407,610 400,063 402,378 3.66%
NOSH 106,981 107,001 106,977 106,987 106,984 106,968 107,015 -0.02%
Ratio Analysis
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
NP Margin 3.22% 3.57% 2.93% 4.75% 4.05% 5.13% 4.68% -
ROE 7.69% 5.76% 2.12% 13.96% 9.39% 8.05% 3.61% -
Per Share
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
RPS 936.83 624.19 296.85 1,215.84 913.11 604.78 293.15 116.80%
EPS 30.51 22.48 8.70 56.26 35.78 30.12 13.57 71.53%
DPS 47.00 47.00 0.00 37.00 27.00 27.00 0.00 -
NAPS 3.97 3.90 4.11 4.03 3.81 3.74 3.76 3.68%
Adjusted Per Share Value based on latest NOSH - 107,001
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
RPS 69.54 46.34 22.03 90.25 67.78 44.89 21.77 116.74%
EPS 2.26 1.67 0.65 4.18 2.66 2.24 1.01 70.99%
DPS 3.49 3.49 0.00 2.75 2.00 2.00 0.00 -
NAPS 0.2947 0.2895 0.3051 0.2992 0.2828 0.2776 0.2792 3.66%
Price Multiplier on Financial Quarter End Date
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
Date 30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 -
Price 4.98 4.98 4.27 4.00 4.09 3.80 3.45 -
P/RPS 0.53 0.80 1.44 0.33 0.45 0.63 1.18 -41.32%
P/EPS 16.32 22.15 49.08 7.11 11.43 12.62 25.42 -25.55%
EY 6.13 4.51 2.04 14.07 8.75 7.93 3.93 34.46%
DY 9.44 9.44 0.00 9.25 6.60 7.11 0.00 -
P/NAPS 1.25 1.28 1.04 0.99 1.07 1.02 0.92 22.64%
Price Multiplier on Announcement Date
30/09/10 30/06/10 31/03/10 31/12/09 30/09/09 30/06/09 31/03/09 CAGR
Date 04/11/10 11/08/10 26/05/10 19/02/10 13/11/09 21/08/09 08/05/09 -
Price 4.92 4.95 4.71 4.05 3.93 4.00 3.82 -
P/RPS 0.53 0.79 1.59 0.33 0.43 0.66 1.30 -44.98%
P/EPS 16.13 22.02 54.14 7.20 10.98 13.28 28.15 -30.98%
EY 6.20 4.54 1.85 13.89 9.10 7.53 3.55 44.97%
DY 9.55 9.49 0.00 9.14 6.87 6.75 0.00 -
P/NAPS 1.24 1.27 1.15 1.00 1.03 1.07 1.02 13.89%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment